CTMS
Integrated Clinical Trial Management
Manage Clinical Trials from Protocol Approval to the Study Closeout through an integrated CTMS on the CARA Life Sciences Platform™. CTMS enables the consistent use of the Study Protocol and Study Master Data along the entire Clinical Trial operations value chain.
Our CTMS provides a single source of truth for all operational Clinical Trial data and workflows. It helps Clinical Trial Managers to make operational decisions based on timely, accurate and consistent data consolidated across simultaneous workstreams like study and site initiation, patient recruitment, monitoring and drug supply.
Reach Across the Organisation
Connect all clinical trial operation workflows through CTMS data & master data.
Align Disparate Workstreams
CTMS on the CARA Life Sciences Platform is the single source of truth for operational data, integrating multiple systems and processes.
Adapt to Evolving Regulations
Conduct clinical trails by adapting the latest regulations to the advantage and safety of enrolled patients.
Data Interoperability
The UI is common between all business processes, reducing training and improving adoption.
Collaboration
Clinical Trial end-to-end support
Cara CTMS enables overarching collaboration across sponsor organisations, regulators, sites, investigators, participants, monitors, CRA’s, and 3rd parties.
Such collaboration maintains and manages all aspects of Clinical Trials including planning, performance reporting, information sharing, tracking of timelines and milestones across a single platform.
Features
Clinical Program / Project Management
Trial and Site Planning
Trial Design
Site and Subject Management
Study Management
Investigator Management
Clinical Supply Tracking
Clinical Trial Performance and Reporting
Latest Resources
Bridging the Gap: AI for Life Sciences Without Compromising Compliance
Generic AI tools can’t handle pharma’s reality. They don’t guarantee audit trails. They fragment your validated systems. They create regulatory risks faster than they solve
Global Pharma Modernises Archiving with CARA Platform
13 Terabytes of content across two repositories 65 Million documents and records requiring migration Ongoing archive requests continuing during migration A global pharmaceutical company needed
Merck: Consolidating 12 Siloed Solutions to a Single Platform with CARA.
85,000 Users 12 Systems Consolidated 18 Million Documents Merck, the oldest pharmaceutical company in the world, implement the CARA Life Sciences Platform to consolidate and
Contact
External Collaboration
Use the tools in CARA to invite users to a time-limited access to the CARA Life Science platform to collaborate on individual document(s). This collaboration is in a secure environment with version control and auditing. The collaboration can include review or collaborative authoring, where multiple users can edit the same document at the same time
